Meet Our Team

A CHLA neurosurgeon explains why thalamic responsive neurostimulation offers a much-needed treatment option for kids with generalized epilepsy.

Children’s Hospital Los Angeles has launched a Neurodevelopmental Disabilities Fellowship, one of the first such programs in the nation.

At 4 years old, Eliot was the first patient at CHLA to receive Elevidys, a groundbreaking new gene therapy for Duchenne muscular dystrophy. The treatment has been a game changer for his health.